AU5873994A - Immune response modulator complex, and uses thereof - Google Patents
Immune response modulator complex, and uses thereofInfo
- Publication number
- AU5873994A AU5873994A AU58739/94A AU5873994A AU5873994A AU 5873994 A AU5873994 A AU 5873994A AU 58739/94 A AU58739/94 A AU 58739/94A AU 5873994 A AU5873994 A AU 5873994A AU 5873994 A AU5873994 A AU 5873994A
- Authority
- AU
- Australia
- Prior art keywords
- immune response
- response modulator
- modulator complex
- complex
- immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000028993 immune response Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99289992A | 1992-12-18 | 1992-12-18 | |
US992899 | 1992-12-18 | ||
PCT/US1993/012479 WO1994014976A1 (en) | 1992-12-18 | 1993-12-20 | Immune response modulator complex, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5873994A true AU5873994A (en) | 1994-07-19 |
Family
ID=25538874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU58739/94A Abandoned AU5873994A (en) | 1992-12-18 | 1993-12-20 | Immune response modulator complex, and uses thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5873994A (en) |
WO (1) | WO1994014976A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19645559A1 (en) * | 1996-11-05 | 1998-05-07 | Immuno Ag | Pharmaceutical antigen / antibody preparation |
CA2324864A1 (en) * | 1998-04-01 | 1999-10-07 | Duke University | Immune response modulator alpha-2 macroglobulin complex |
US6403092B1 (en) | 1998-04-01 | 2002-06-11 | Duke University | Immune response modulator alpha-2 macroglobulin complex |
JP2004505894A (en) | 2000-06-02 | 2004-02-26 | ユニバーシティー オブ コネティカット ヘルス センター | Complex of α (2) macroglobulin and antigen molecule for immunotherapy |
US7179462B2 (en) | 2000-06-02 | 2007-02-20 | University Of Connecticut Health Center | α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
US7186515B1 (en) | 2000-06-02 | 2007-03-06 | University Of Connecticut Health Center | Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
EP1536829A4 (en) | 2001-08-20 | 2006-05-31 | Univ Connecticut Health Ct | Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
AU2003231098A1 (en) | 2002-04-25 | 2003-11-10 | University Of Connecticut Health Center | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
US6984389B2 (en) | 2002-04-25 | 2006-01-10 | University Of Connecticut Health Center | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
DE602004030541D1 (en) | 2003-02-20 | 2011-01-27 | Univ Connecticut Health Ct | PROCESS FOR PREPARING ALPHA (2) MACROGLOBULIN ANTIGEN MOLECULAR COMPLEXES |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992007003A1 (en) * | 1990-10-18 | 1992-04-30 | University Of Guelph | MODIFIED α2-MACROGLOBULINS AND THEIR USE AS SCAVENGERS FOR CYTOKINES AND GROWTH FACTORS |
-
1993
- 1993-12-20 AU AU58739/94A patent/AU5873994A/en not_active Abandoned
- 1993-12-20 WO PCT/US1993/012479 patent/WO1994014976A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1994014976A1 (en) | 1994-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3570193A (en) | Altered antibodies, products and processes relating thereto | |
AU5827794A (en) | Object oriented application interface | |
EP0592202A3 (en) | D-ketohexose 3-epimerase, and its preparation and uses. | |
AU3377093A (en) | Sulphonylbenzyl-substituted pyridones | |
AU9075591A (en) | N-halochitosans, their preparation and uses | |
AU3561193A (en) | TNF-muteins | |
AU3991693A (en) | Pyrazinoindoles | |
AU3397793A (en) | Binder and its uses | |
AU3686793A (en) | Thermo-actuator | |
AU3042892A (en) | Rockbolt | |
AU4177593A (en) | Benzophenonehydrazones | |
AU3710993A (en) | Biphenylmethyl-substituted pyridones | |
AU5067193A (en) | Pyranoquinolines and their use as pharmaceuticals | |
AU5873994A (en) | Immune response modulator complex, and uses thereof | |
AU4156393A (en) | Heterocyclyltriazolinones | |
AU4238093A (en) | Novel retinol derivatives and uses thereof | |
AU5680594A (en) | Pad, tape and forming methods | |
AU4424793A (en) | Business form | |
AU1023792A (en) | Multi-donor booster operation and system | |
AU664253B2 (en) | Photo-deviometer | |
AU3461693A (en) | Saddle-cloth | |
AU3562193A (en) | Morpholin- and thiomorpholin-4-ylamides | |
AU6262594A (en) | Clipboard | |
AU4164793A (en) | Heterocyclyltriazolinones | |
AU1764292A (en) | Re-catalyst and carrier |